Propiolactone
Drug profile
Also known as: 1,3-propiolactone, 2-Oxetanone, beta-propiolactone, betaprone, hydracrylic acid beta-lactone, propanolide, propiolattone
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Propiolactone is a drug catalogued in DrugCentral. Recorded indications include Antiseptic preparation.
- Indications: Antiseptic preparation.
- Molecular formula: C3H4O2; molecular weight 72.06 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Antiseptic preparation
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | FOREST LABS |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Propiolactone is on its molecule page.
| Molecular formula | C3H4O2 |
|---|---|
| Molecular weight | 72.06 g/mol |
| CAS number | 57-57-8 |
| InChIKey | VEZXCJBBBCKRPI-UHFFFAOYSA-N |
| PubChem CID | 2365 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Propiolactone used for?
DrugCentral lists the following indications for Propiolactone: Antiseptic preparation.
What is the chemical formula of Propiolactone?
Propiolactone has the molecular formula C3H4O2 and a molecular weight of 72.06 g/mol.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3495 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200627 — compound record and bioactivity
- PubChem CID 2365 — chemical identifiers
- DrugBank DB09348 — drug record
- FDA UNII 6RC3ZT4HB0 — substance identity
- DailyMed: FDA labels for Propiolactone — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.